Strive Pharmacy
“Semaglutide/Glycine/B12 injection — 90-day titration & maintenance bundles via Strive Pharmacy.”
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 7.6/10
Best for: compounded semaglutide with glycine and B12 in 90-day bundles from a named pharmacy
Peptivo scores highest on the clinical side (which drugs it prescribes and how it doses) and lowest on availability. Its compounded semaglutide costs $179 a month, 10% below the $199 median among the sellers we compare.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Covered by the monthly price
Medication
In the price
Clinician visits
In the price
Shipping
In the price
Lab work
Not stated
Coaching
Not stated
Prices checked October 2026
Peptivo is a telehealth storefront whose live weight program sells compounded semaglutide and tirzepatide, each blended with glycine and B12, in 90-day bundles filled by Strive Pharmacy. It quotes them only per day, from $3.19 and $7.06, under a summer promo, and its storefront shows no monthly or bundle total, though its terms list monthly packages at $179 for semaglutide and $279 for tirzepatide. Its money-back guarantee is not in its refund terms. A sermorelin nasal program is also live. It names no company behind the brand.
Peptivo does not name the company behind it anywhere on its site or in its legal pages, so we could not confirm who you would be buying from. We found no FDA warning letters issued under the Peptivo name. We rate it 7.6/10 overall, across six areas from price to trust and safety. Find out who operates it before you pay, and raise any doubts with a licensed clinician.
We know of no promo or coupon code for Peptivo. Its listed price is $179 a month. Coupon sites advertising "Peptivo discount codes" are not a source we can vouch for, and any genuine offer shows at checkout without a code.
See how Peptivo compares on our rankings of the best semaglutide providers and the best tirzepatide providers.
Best for: flat any-dose pricing, if you can absorb a $199 annual membership on top
Editorial score · methodology
Best for: a flat compounded tirzepatide or semaglutide price at every dose, from a seller that names its pharmacies
Editorial score · methodology
Best for: moving between compounded and brand without changing seller
Editorial score · methodology
Six columns, each one computed from something Peptivo has published rather than from an opinion we formed: what it charges, which molecules it will dispense, what its record shows, and what the monthly figure actually buys. Where a seller keeps something back, such as its price or its pharmacy, the score reflects it. Every seller we review goes through the same six columns.
$179/month is 10% below the $199 median for compounded semaglutide across the sellers we compare.
Dispenses semaglutide and tirzepatide, including the FDA-approved product. Anchored to SURMOUNT-1 (tirzepatide, -20.9%) and STEP 1 (semaglutide, -14.9%).
A price is shown before the questionnaire starts.
It names the pharmacy that fills its prescriptions. It shows a price before asking for health information.
No state list is available to check, so this is held at the midpoint rather than scored on reach.
The price covers the medication, clinician visits and shipping.
A seller that shows no price until after the medical intake loses points on User Experience and Trust & Safety, and its review says so. How we score →
Price, availability, and compliance here are read off the seller's own pages and off primary regulatory records, named in the sources below.
What to expect on the way to a prescription: where the price appears, who fills the medication, and what the monthly price covers. It is not medical advice, and a clinician makes the prescribing decision.
Taken from the terms Peptivo publishes. Terms change, so check the current policy before you subscribe.
Peptivo lists Ozempic, Zepbound, compounded semaglutide and compounded tirzepatide. Each one has its own guide: how it works, the dosing schedule, the side effects that show up in practice, and what the trials measured.
Peptivo sells peptides beyond the GLP-1s. Tap one to read what the evidence says about it.
Prices re-verified
/pages/terms: "Follow-Up Consultation - Semaglutide Priced at $179". Storefront shows "from $3.19 /day" on 90-day bundles.
/pages/terms: "Follow-Up Consultation - Tirzepatide Priced at $279". Storefront shows "from $7.06 /day".
/pages/terms: "Initial Consultation - Ozempic Priced at $1,299 for the first month"; follow-up the same. Not on the storefront.
/pages/terms: "Initial Consultation - Zepbound Priced at $1,399 for the first month"; follow-up the same. Not on the storefront.
Check the price yourself before you pay
Every figure here comes from Peptivo's own website, as of the date shown. Sellers move prices without announcing it, and promotional rates lapse, so confirm the standing cost on their site before committing.
Peptivo names each pharmacy below as one that compounds or fills its prescriptions, in its own site, terms or filings. The quote under each one is the seller’s own wording.
“Semaglutide/Glycine/B12 injection — 90-day titration & maintenance bundles via Strive Pharmacy.”
Peptivo lists $179/month, flat regardless of dose. That sits at the affordable end of what we see. Flat dose pricing matters more than it sounds: on a tiered plan the bill grows with the dose, so the figure that got you to sign up is not the one you end up paying.
For compounded semaglutide, the median across the sellers we compare is $199/month, so Peptivo's $179 is genuinely below the middle, not just advertised that way. Before you pay, compare Peptivo's cancellation terms with other sellers' cancellation and refund policies. Across the compounded market the dearest tenth of sellers charges about three times what the cheapest tenth does; how much GLP-1 prices actually vary explains the spread.
Bodybuilding Health+, at about $179/month, is the closest like-for-like alternative we review.
Peptivo prescribes semaglutide (approved as Wegovy and Ozempic) and tirzepatide (approved as Zepbound and Mounjaro). Between them these are the two molecules with the largest published weight-loss trial programs behind them. Both routes are available: the FDA-approved pen, or a compounded version at lower cost. The difference is not cosmetic. The approved product has been reviewed for safety, efficacy and manufacturing quality, and a compounded preparation has not. The molecule can be the one in Ozempic and Wegovy; what differs is the formulation, the concentration and the dose ladder.
Peptivo tells you its price before you start the medical questionnaire and the pharmacy that fills its prescriptions. We found no FDA warning letters issued to Peptivo. Because the medication is compounded, the named pharmacy is the detail that matters most: its license is the one you can look up. The FDA's warning signs for online medicine sellers are a quick check to run on any seller before you pay. How we weigh oversight, disclosure and price is set out in our scoring methodology.
Peptivo also sells sermorelin, which no published trial has tested for weight loss.
Peptivo competes on price without an obvious sacrifice elsewhere: $179/month, no FDA warning letters.
The Bottom Line
Peptivo scores highest on the clinical side (which drugs it prescribes and how it doses) and lowest on availability. Its compounded semaglutide costs $179 a month, 10% below the $199 median among the sellers we compare.
Starting at $179 a month. Check today's price, then start the intake.
No seller suits every reader, and pretending otherwise is the easiest way to sell one. On these two counts, another seller does better.
If none of these fits, our guide to alternatives to Peptivo sets more sellers in the same category beside Peptivo on price, states and what the price includes.
The words sellers use, defined. Tap any term.
Cited across this Peptivo review: primary regulatory filings, and peer-reviewed studies.
Plans start at $179 a month. Whether you qualify is a clinician's decision, made after your intake.